FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,953,000 | +175.0% | 158,042 | +24.1% | 0.00% | +300.0% |
| Q4 2020 | $2,165,000 | +2001.9% | 127,327 | +483.7% | 0.00% | – |
| Q3 2020 | $103,000 | -36.0% | 21,814 | -17.6% | 0.00% | – |
| Q2 2020 | $161,000 | -48.2% | 26,468 | -48.6% | 0.00% | -100.0% |
| Q2 2019 | $311,000 | +182.7% | 51,544 | +334.2% | 0.00% | – |
| Q4 2018 | $110,000 | -45.3% | 11,870 | +77.8% | 0.00% | -100.0% |
| Q2 2017 | $201,000 | -63.3% | 6,677 | -50.5% | 0.00% | -66.7% |
| Q1 2016 | $548,000 | +84.5% | 13,488 | +13.0% | 0.00% | +50.0% |
| Q2 2015 | $297,000 | – | 11,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |